Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture
- 1 January 1995
- Vol. 13 (16) , 1583-1588
- https://doi.org/10.1016/0264-410x(95)00085-f
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Mixed populations in influenza virus vaccine strainsVaccine, 1994
- Analysis of the Restriction to the Growth of Nonegg-Adapted Human Influenza Virus in EggsVirology, 1993
- The role of amniotic passage in the egg-adaptation of human influenza virus is revealed by haemagglutinin sequence analysesJournal of General Virology, 1993
- Clinical influenza virus and the embryonated Hen's eggReviews in Medical Virology, 1993
- Efficacy of Inactivated Influenza A Virus (H3N2) Vaccines Grown in Mammalian Cells or Embryonated EggsThe Journal of Infectious Diseases, 1989
- Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin moleculeVirology, 1989
- Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individualVirology, 1988
- Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virusVirology, 1987
- Evidence for host-cell selection of influenza virus antigenic variantsNature, 1983
- Similar frequencies of antigenic variants in Sendai, vesicular stomatitis, and influenza A virusesVirology, 1980